Quantification of apixaban's therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose (Q42945852)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 4, 2010
edit
Language Label Description Also known as
English
Quantification of apixaban's therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose
scientific article published on August 4, 2010

    Statements

    Quantification of apixaban's therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit